Filter By “Linking Real-World Data”

Health Data Trends Part I: Top Trends in Health Data Demand

As Head of Data Strategy at Datavant, I help clients find partners with relevant real-world data (RWD) for linkage to their own data or to create multi-partner linked datasets. These clients include pharmaceutical companies, health systems, government, payers, and analytics platforms. Connecting data helps them create a robust picture of patient health to accelerate research, improve care, and lower healthcare costs.

Read More
post-image
Synthetic Data: The Newest Tool in the Privacy Protection Tool Kit

Synthetic data is the latest breakthrough in privacy-protected health data. Join a panel with Carter Prince, Head of Growth at Syntegra, Jamie Gray, Chief Operating Officer at Mirador Analytics, Su Huang, Head of Data Strategy at Datavant, and Ofer Mendelevitch, Chief Technology Officer at Syntegra in a conversation about situations where maintaining patient privacy calls for an entirely new approach – Synthetic Data. Learn more about what it is, how it’s created and when it makes sense to employ synthetic data in your health data strategy.

Read More
post-image
How to Conduct More Effective HEOR Analyses with Linked Data
Read More
post-image
Overcoming the Challenges of Connecting Trial Site Data to Real World Data – The Latest Innovations in Data Connectivity

Connecting real world data to clinical trials holds promise for researchers and patients. It can extend the observation period of studies and supplement data for patients lost to follow up.

Read More
post-image
Research Using Connected Health Data
Read More
post-image
Amivantamab compared with real-world therapies in patients with NSCLC with EGFR Exon 20 insertion mutations who have progressed after platinum doublet chemotherapy

Amivantamab is an epidermal growth factor receptor (EGFR)-MET bispecific antibody with immune cell-directing activity.

LEARN MORE
post-image
Privacy Hub: Technology-Enabled Expert Determination and HIPAA Compliance
Read More
Datavant Supports FDA Guidance with a Privacy-first Approach to Using Real World Evidence for Regulatory Decision Making

Datavant submitted comments on the recently issued FDA’s guidance that helped to clarify how real world data could be made “fit for purpose” in regulatory decision-making.

Read More
Can Connected Health Data Help Close the Gap in U.S. Maternal Mortality Rates?

Today, we are excited to announce the launch of Privacy Hub, one of the core components of Datavant’s Switchboard, which makes it easier for companies to safely connect data. At the same time, we are announcing the acquisition of Mirador Analytics, the leading provider of HIPAA expert determination services and technology.  

Read More